-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Versigent, Raises Price Target to $56

Benzinga·08/05/2026 15:10:05
Listen to the news
Wells Fargo analyst Colin Langan maintains Versigent (NYSE:VGNT) with a Overweight and raises the price target from $48 to $56.